Compare ACOG & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | PRE |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 131.3M |
| IPO Year | N/A | N/A |
| Metric | ACOG | PRE |
|---|---|---|
| Price | $5.08 | $14.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $18.00 | ★ $32.00 |
| AVG Volume (30 Days) | 84.0K | ★ 137.5K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,427,199.00 | ★ $77,079,000.00 |
| Revenue This Year | N/A | $219.28 |
| Revenue Next Year | $143.70 | $124.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 201.54 |
| 52 Week Low | $3.75 | $3.10 |
| 52 Week High | $11.54 | $17.99 |
| Indicator | ACOG | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 32.34 | 53.29 |
| Support Level | $5.66 | $12.93 |
| Resistance Level | $6.74 | $15.70 |
| Average True Range (ATR) | 0.41 | 1.12 |
| MACD | -0.06 | 0.07 |
| Stochastic Oscillator | 0.00 | 56.68 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.